Synthesis and characterization of 5,7-dihydroxyflavanone derivatives as novel protein tyrosine phosphatase 1B inhibitors

References

• Neel BG, Tonks NK. Protein tyrosine phosphatases in signal transduction. Curr Opin Cell Biol 1997;9:193–204.
   PubMed Web of Science ®Google Scholar
• Tonks NK, Neel BG. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr Opin Cell Biol 2001;13:182–195.
   PubMed Web of Science ®Google Scholar
• Hunter T. Signaling–2000 and beyond. Cell 2000;100:113–127.
   PubMed Web of Science ®Google Scholar
• Lee S, Wang Q. Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B. Med Res Rev 2007;27:553–573.
   PubMedGoogle Scholar
• Cook WS, Unger RH. Protein tyrosine phosphatase 1B: a potential leptin resistance factor of obesity. Dev Cell 2002;2:385–387.
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411:355–365.
   PubMed Web of Science ®Google Scholar
• Montalibet J, Kennedy BP. Therapeutic strategies for targeting PTP1B in diabetes. Drug Discov Today: Therap Strateg 2005;2:129–135.
   Google Scholar
• Johnson TO, Ermolieff J, Jirousek MR. Protein tyrosine phosphatase 1B inhibitors for diabetes. Nat Rev Drug Discov 2002;1:696–709.
   PubMed Web of Science ®Google Scholar
• Liu G, Trevillyan JM. Protein tyrosine phosphatase 1B as a target for the treatment of impaired glucose tolerance and type II diabetes. Curr Opin Investig Drugs 2002;3:1608–1616.
   PubMedGoogle Scholar
• Tobin JF, Tam S. Recent advances in the development of small molecule inhibitors of PTP1B for the treatment of insulin resistance and type 2 diabetes. Curr Opin Drug Discov Devel 2002;5:500–512.
   PubMed Web of Science ®Google Scholar
• Cheng A, Uetani N, Simoncic PD, Chaubey VP, Lee-Loy A, McGlade CJ et al. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell 2002;2:497–503.
   PubMed Web of Science ®Google Scholar
• Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 1999;283:1544–1548.
   PubMed Web of Science ®Google Scholar
• Klaman LD, Boss O, Peroni OD, Kim JK, Martino JL, Zabolotny JM et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol 2000;20:5479–5489.
   PubMed Web of Science ®Google Scholar
• Rondinone CM, Trevillyan JM, Clampit J, Gum RJ, Berg C, Kroeger P et al. Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis. Diabetes 2002;51:2405–2411.
   PubMed Web of Science ®Google Scholar
• Zinker BA, Rondinone CM, Trevillyan JM, Gum RJ, Clampit JE, Waring JF et al. PTP1B antisense oligonucleotide lowers PTP1B protein, normalizes blood glucose, and improves insulin sensitivity in diabetic mice. Proc Natl Acad Sci USA 2002;99:11357–11362.
   PubMed Web of Science ®Google Scholar
• Ramachandran C, Kennedy BP. Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity. Curr Top Med Chem 2003;3:749–757.
   PubMed Web of Science ®Google Scholar
• Gum RJ, Gaede LL, Koterski SL, Heindel M, Clampit JE, Zinker BA et al. Reduction of protein tyrosine phosphatase 1B increases insulin-dependent signaling in ob/ob mice. Diabetes 2003;52:21–28.
   PubMed Web of Science ®Google Scholar
• Zhang YN, Zhang W, Hong D, Shi L, Shen Q, Li JY et al. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorg Med Chem 2008;16:8697–8705.
   PubMed Web of Science ®Google Scholar
• Combs AP. Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer. J Med Chem 2010;53:2333–2344.
   PubMed Web of Science ®Google Scholar
• Na M, Jang J, Njamen D, Mbafor JT, Fomum ZT, Kim BY et al. Protein tyrosine phosphatase-1B inhibitory activity of isoprenylated flavonoids isolated from Erythrina mildbraedii. J Nat Prod 2006;69:1572–1576.
   PubMed Web of Science ®Google Scholar
• Wang Y, Shang XY, Wang SJ, Mo SY, Li S, Yang YC et al. Structures, biogenesis, and biological activities of pyrano[4,3-c]isochromen-4-one derivatives from the Fungus Phellinus igniarius. J Nat Prod 2007;70:296–299.
   PubMed Web of Science ®Google Scholar
• Combs AP, Zhu W, Crawley ML, Glass B, Polam P, Sparks RB et al. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic. J Med Chem 2006;49:3774–3789.
   PubMed Web of Science ®Google Scholar
• Wilson DP, Wan ZK, Xu WX, Kirincich SJ, Follows BC, Joseph-McCarthy D et al. Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site. J Med Chem 2007;50:4681–4698.
   PubMed Web of Science ®Google Scholar
• Matsuda H, Wang T, Managi H, Yoshikawa M. Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 2003;11:5317–5323.
   PubMed Web of Science ®Google Scholar
• Matsuda H, Morikawa T, Ando S, Toguchida I, Yoshikawa M. Structural requirements of flavonoids for nitric oxide production inhibitory activity and mechanism of action. Bioorg Med Chem 2003;11:1995–2000.
   PubMed Web of Science ®Google Scholar
• Pouget C, Lauthier F, Simon A, Fagnere C, Basly JP, Delage C et al. Flavonoids: structural requirements for antiproliferative activity on breast cancer cells. Bioorg Med Chem Lett 2001;11:3095–3097.
   PubMed Web of Science ®Google Scholar
• Pouget C, Fagnere C, Basly JP, Habrioux G, Chulia AJ. New aromatase inhibitors. Synthesis and inhibitory activity of pyridinyl-substituted flavanone derivatives. Bioorg Med Chem Lett 2002;12:1059–1061.
   PubMedGoogle Scholar
• Maliar T, Jedinák A, Kadrabová J, Sturdík E. Structural aspects of flavonoids as trypsin inhibitors. Eur J Med Chem 2004;39:241–248.
   PubMed Web of Science ®Google Scholar
• Cui L, Na M, Oh H, Bae EY, Jeong DG, Ryu SE et al. Protein tyrosine phosphatase 1B inhibitors from Morus root bark. Bioorg Med Chem Lett 2006;16:1426–1429.
   PubMed Web of Science ®Google Scholar
• Cui L, Ndinteh DT, Na M, Thuong PT, Silike-Muruumu J, Njamen D et al. Isoprenylated flavonoids from the stem bark of Erythrina abyssinica. J Nat Prod 2007;70:1039–1042.
   PubMed Web of Science ®Google Scholar
• Cui L, Thuong PT, Lee HS, Ndinteh DT, Mbafor JT, Fomum ZT et al. Flavanones from the stem bark of Erythrina abyssinica. Bioorg Med Chem 2008;16:10356–10362.
   PubMed Web of Science ®Google Scholar
• Cui L, Lee HS, Ndinteh DT, Mbafor JT, Kim YH, Le TV et al. New prenylated flavanones from Erythrina abyssinica with protein tyrosine phosphatase 1B (PTP1B) inhibitory activity. Planta Med 2010;76:713–718.
   PubMed Web of Science ®Google Scholar
• Nguyen PH, Dao TT, Kim J, Phong do T, Ndinteh DT, Mbafor JT et al. New 5-deoxyflavonoids and their inhibitory effects on protein tyrosine phosphatase 1B (PTP1B) activity. Bioorg Med Chem 2011;19:3378–3383.
   PubMed Web of Science ®Google Scholar
• Zhao DH, Sui X, Qu YL, Yang LY, Wang X, Guan LP. Synthesis and studies on antidepressant effect of 5,7-dihydroxyflavanone derivatives. Asian J Chem 2011;23:1129–1132.
   Google Scholar
• Shi L, Yu HP, Zhou YY, Du JQ, Shen Q, Li JY et al. Discovery of a novel competitive inhibitor of PTP1B by high-throughput screening. Acta Pharmacol Sin 2008;29:278–284.
   PubMedGoogle Scholar
• McGovern SL, Helfand BT, Feng B, Shoichet BK. A specific mechanism of nonspecific inhibition. J Med Chem 2003;46:4265–4272.
   PubMed Web of Science ®Google Scholar
• Zhang W, Hong D, Zhou Y, Zhang Y, Shen Q, Li JY et al. Ursolic acid and its derivative inhibit protein tyrosine phosphatase 1B, enhancing insulin receptor phosphorylation and stimulating glucose uptake. Biochim Biophys Acta 2006;1760:1505–1512.
   PubMed Web of Science ®Google Scholar
• Zhao LM, Jin HS, Sun LP, Piao HR, Quan ZS. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives. Bioorg Med Chem Lett 2005;15:5027–5029.
   PubMed Web of Science ®Google Scholar
• Dong X, Liu Y, Yan J, Jiang C, Chen J, Liu T et al. Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents. Bioorg Med Chem 2008;16:8151–8160.
   PubMedGoogle Scholar
• Zhao H, Liu G, Xin Z, Serby MD, Pei Z, Szczepankiewicz BG et al. Isoxazole carboxylic acids as protein tyrosine phosphatase 1B (PTP1B) inhibitors. Bioorg Med Chem Lett 2004;14:5543–5546.
   PubMed Web of Science ®Google Scholar
• Liu G, Xin Z, Pei Z, Hajduk PJ, Abad-Zapatero C, Hutchins CW et al. Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor. J Med Chem 2003;46:4232–4235.
   PubMed Web of Science ®Google Scholar
• Ducruet AP, Vogt A, Wipf P, Lazo JS. Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer’s disease. Annu Rev Pharmacol Toxicol 2005;45:725–750.
   PubMedGoogle Scholar